Pham Quang X Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$100,133.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Pham Quang X

According to the SEC Form 4 filings, Pham Quang X, being in a position of

  1. Chairman and CEO at Cadrenal Therapeutics, Inc. Common Stock,
    оver the last 12 months, has bought 0 shares, and sold 97500 shares for $388,290,
    over all time since 2023-09-01, has bought 110000 shares for $100,133, and sold 119744 shares for $700,646.

Biography of Pham Quang X

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $388,29022100

Comparison of Insiders on Amount of Buys and Sells

2026-06-29SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman and CEO
7,400
0.2412%
$3.03$22,422-50%
2026-06-26SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
9,029
0.3128%
$3.05$27,538-50.16%
2026-06-25SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
2,127
0.0725%
$3.00$6,381-46.5%
2026-06-23SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
2,277
0.0774%
$3.20$7,286-49.67%
2026-06-22SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
9,167
0.3324%
$3.55$32,543-51.42%
2026-06-17SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
513
0.0182%
$3.16$1,621-49.68%
2026-06-16SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
3,613
0.1318%
$3.18$11,489-48.36%
2026-06-15SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
3,666
0.1237%
$3.58$13,124-52.85%
2026-06-12SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
12,996
0.4825%
$3.94$51,204-57.57%
2026-06-11SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
1,462
0.0521%
$4.12$6,023-60.79%
2026-06-10SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
3,500
0.1301%
$4.21$14,735-61.59%
2026-06-09SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
12,992
0.4656%
$4.06$52,748-59.49%
2026-06-08SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
Chairman, CEO and Interim CFO
5,893
0.2138%
$4.38$25,811-61.76%
2026-06-05SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
CEO and Chairman
2,064
0.0738%
$4.42$9,123-63.4%
2026-06-04SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
CEO and Chairman
3,898
0.1391%
$4.41$17,190-61.95%
2026-06-03SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
CEO and Chairman
2,323
0.0823%
$4.26$9,896-60.02%
2026-06-02SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
CEO and Chairman
349
0.0115%
$4.46$1,557-60.69%
2026-05-29SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
CEO and Chairman
303
0.0107%
$5.01$1,518-64.72%
2026-05-28SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
CEO and Chairman
2,989
0.1028%
$4.93$14,736-64.9%
2026-05-22SaleCadrenal Therapeutics, Inc. Common Stock
CVKD
CEO and Chairman
1,165
0.0445%
$5.69$6,629-64.55%
Total: 35
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.